Strategies and Considerations for Improving Expression of “Difficult to Express” Proteins in CHO Cells
Author:
Publisher
Springer New York
Link
http://link.springer.com/content/pdf/10.1007/978-1-4939-6972-2_1
Reference111 articles.
1. Ohya T, Hayashi T, Kiyama E et al (2008) Improved production of recombinant human antithrombin III in Chinese hamster ovary cells by ATF4 overexpression. Biotechnol Bioeng 100:317–324. doi: 10.1002/bit.21758
2. Novo JB, Morganti L, Moro AM et al (2012) Generation of a Chinese hamster ovary cell line producing recombinant human glucocerebrosidase. J Biomed Biotechnol 2012:875383. doi: 10.1155/2012/875383
3. Le Fourn V, Girod P-A, Buceta M et al (2014) CHO cell engineering to prevent polypeptide aggregation and improve therapeutic protein secretion. Metab Eng 21:91–102. doi: 10.1016/j.ymben.2012.12.003
4. Jiang Z, Huang Y, Sharfstein ST (2006) Regulation of recombinant monoclonal antibody production in chinese hamster ovary cells: a comparative study of gene copy number, mRNA level, and protein expression. Biotechnol Prog 22:313–318
5. Nishimiya D, Mano T, Miyadai K et al (2013) Overexpression of CHOP alone and in combination with chaperones is effective in improving antibody production in mammalian cells. Appl Microbiol Biotechnol 97:2531–2539. doi: 10.1007/s00253-012-4365-9
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Large-Scale Comparative Transcriptomic Analysis of CHO Cell Functional Adaptation to Recombinant Monoclonal Antibody Production;2024-07-01
2. Nature as blueprint: Global phenotype engineering of CHO production cells based on a multi-omics comparison with plasma cells;Metabolic Engineering;2024-05
3. CHO synthetic promoters improve expression and product quality of biotherapeutic proteins;Biotechnology Progress;2023-04-28
4. Recombinant vaccines in 2022: a perspective from the cell factory;Microbial Cell Factories;2022-10-05
5. Factors Affecting the Expression of Recombinant Protein and Improvement Strategies in Chinese Hamster Ovary Cells;Frontiers in Bioengineering and Biotechnology;2022-07-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3